MedTrace Logo

rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers

NCT03865472 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2026-02-10

No results posted yet for this study

Summary

This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves cognitive function.

Conditions

  • Cigarette Smoker
  • Current Every Day Smoker
  • Current Smoker

Interventions

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Repetitive Transcranial Magnetic Stimulation

Undergo rTMS

PROCEDURE

Sham Intervention

Undergo sham rTMS

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Christine Sheffer · Roswell Park Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-10
Primary Completion
2025-11-13
Completion
2026-11-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03865472 on ClinicalTrials.gov